期刊文献+

178例三阴性乳腺癌的临床病理特征及生存分析 被引量:2

Analysis of Clinicopathological Characteristics and Prognosis for Triple Negative Breast Cancer:Report of 178 Cases
暂未订购
导出
摘要 目的探讨三阴性乳腺癌(TNBC)患者的临床病理特点、生存情况和预后影响因素。方法收集雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)均阴性的178例乳腺癌患者的临床病理资料,观察其长期生存状况。分析其临床特点及影响预后的因素。结果有乳腺癌家族史的患者4例。主要病理类型为浸润性导管癌(155/178,87.1%)。组织学分级多为Ⅲ级(53.1%)。中位肿瘤最大径2.8 cm(0.2~12 cm),T1、T2期患者160例占89.9%。108例(61.7%)患者无淋巴结转移。分期为Ⅰ、Ⅱ、Ⅲ期的患者分别有60例(33.7%)、81例(45.5%)、31例(17.4%)。58例(48.3%)患者p53阳性。中位随访时间74月(10~156月),5年无病生存(DFS)和总生存(OS)率分别是76.9%和86.1%。单因素分析显示T分期、临床分期及淋巴结转移对DFS和OS均有显著影响。多因素分析显示,淋巴结转移是DFS及OS的独立影响因素。而术后分期是OS的影响因素。共有41例患者出现复发转移及第二原发肿瘤,常见转移部位依次为骨转移、局部复发或同侧锁骨上淋巴结转移、肺或胸膜转移、肝转移及脑转移。结论本组TNBC肿瘤直径较小,组织学分级低分化比例较高(53.1%)。复发转移以骨转移、局部复发及肺转移为主。淋巴结转移及术后分期是总生存的独立危险因素。 Objective To investigate the clinicopathological characteristics,survival and prognostic factors of patients with triple negative breast cancer(TNBC).Methods One hundred and seventy-eight patients who were diagnosed as breast cancer with negative estrogen receptor(ER),progesterone receptor(PR),and human epidermal growth factor receptor-2(HER2) at Peking university third hospital were enrolled to collect clinicopathological factors and survival status.Clinical characteristics and prognostic factors were analyzed.Results Four patients had breast cancer family history.One hundred and fifty-five patients(87.1%) had invasive ductal carcinomas,which was the majority of pathological types.53.1% TNBC patients were grade Ⅲ,and 160(89.9%) of the tumors were staged T1 or T2.The median clinical tumor size was2.8 cm(0.2~12 cm).One hundred and eight patients(61.7%)had no lymph node metastasis.According to TNM staging system,60 patients(33.7%) were stage Ⅰ,81 patients(45.5%) were stage Ⅱ,and 31 patients(17.4%) were stage Ⅲ.58 patients(48.3%) had positive p53.With median follow up time of 74.0 months(range 10~156 months),the 5-year cumulative disease free survival(DFS) of all patients was 76.9%.5-year cumulative overall survival(OS) was 86.1%.T stage,TNM stage and lymph node metastasis status were all correlated with DFS and OS in the univariate analysis.In the multivariate analysis,the lymph node metastasis status was found to be an independent prognostic factor for both DFS and OS,and clinical stage was an independent prognostic factor for OS.In total,41 patients were recorded with tumor relapse or metastasis or a second primary tumor.The common metastasis sites were bones,local recurrence or ipsilateral supraclavicular node,lung or pleural,liver and brain.Conclusion In these TNBC patients,the tumors were small,and more than half were low-histology stage.The main recurrence or metastasis sites were bones,local region and lung.Lymph node metastasis and TNM stage were both independent prognostic factors for OS.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第4期412-416,共5页 Cancer Research on Prevention and Treatment
关键词 三阴性乳腺癌 病理特征 预后 Triple negative breast cancer Pathological characteristics Prognosis
  • 相关文献

参考文献12

  • 1l)e 1.aurentiis M,Cianniello D,Caputo R,et al . Treatment of triple negative breast cancer (TNBC) :current options and fu ture perspectivcs[J]. Cancer Treat Rev,2010,36(suppl 3) 3: S80-86.
  • 2关印,徐兵河.三阴性乳腺癌的临床病理特征及预后分析[J].中华肿瘤杂志,2008,30(3):196-199. 被引量:62
  • 3何奇,王杰,邵玉国,周晓云,邵志敏.三阴性乳腺癌的临床病理特征与预后分析[J].中华医学杂志,2009,89(4):243-247. 被引量:14
  • 4(;omen E, Davids M, Kirchhoff T, et al. Relative contributions of BRCA1 and BRCA2 mutations to "triple negative" breastcancer in Ashkenazi Women[J]. Breast Cancer Res Treat, 201/ ,129(1):185 190.
  • 5Oakman C, Viale G,Di Leo A. Management of triple negative breast cancer[J]. Breast,2010,19(5) :312-321.
  • 6Sanpaolo P,Barbieri V,Genovesi D. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant me- tastases and local relapse rates in conservatively managed early stage breast cancer= A retrospective clinical st udy[J ]. Eur J Surg Oneol,2011,37(10) :876-882.
  • 7Dent R, Trudeau M, Pritchard KI, et al. Triple negative breast cancer: clinical features and patterns of recurrence [J]. Clin Cancer Res,2007,13(15 Pt 1) :4429-4434.
  • 8张萍,徐兵河,马飞,李俏,袁苑,王佳玉,张频.晚期三阴性乳腺癌的临床特征及生存分析[J].中华肿瘤杂志,2011,33(5):381-384. 被引量:32
  • 9Perez EA, Moreno-Aspitia A, Aubrey Thompson E, et al. Ad- iuvant therapy of triple negative breast cancer[J]. Breast Cane- er Res Treat,2010,120(2):285-291.
  • 10Hugh J, Hanson J, Cheang MC, et al. Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial[J]. J Clin ()ncol,2009,27(8) : / 168-1/76.

二级参考文献42

  • 1宋传贵,胡震,袁文涛,狄根红,沈镇宙,黄薇,邵志敏.上海地区早发性乳腺癌患者BRCA1和BRCA2基因突变分析[J].中华医学杂志,2005,85(43):3030-3034. 被引量:26
  • 2张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 3赵卫红,徐兵河,张频,李青,赵龙妹,孙燕.乳腺癌合并脉管瘤栓的临床病理特点及预后因素分析[J].中华肿瘤杂志,2007,29(2):137-140. 被引量:14
  • 4Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 2006, 295:2492-2502.
  • 5Carlson RW, Moench SJ, Hammond ME, et al. HER2 testing in breast cancer: NCCN Task Force report and recoannendations. J Natl Compr Canc Netw, 2006, 4 Suppl 3 :S1-22.
  • 6Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol, 2007, 8:235-244.
  • 7Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32.
  • 8Perez EA, Roche PC, Jenkins RB, et al. HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc, 2002, 77:148-154.
  • 9Kandel MJ, Stadler Z, Masciari S, et al. Prevalence of BRCA1 mutations in triple negative breast cancer (BC). Proc Am Soc Clin Oncol, 2006, 24 :abstr 508.
  • 10Herr A, Gluz O, Ting E, et al. Biological characteristics in triple negative high risk breast cancer and their clinical implications. Proc Am Soc Clin Oncol, 2006, 24 : abstr 20032.

共引文献100

同被引文献23

  • 1杨文涛,张廷璆,沈铭昌,袁亚.乳腺腺样囊性癌临床病理特点及文献复习[J].临床与实验病理学杂志,2005,21(1):10-13. 被引量:28
  • 2乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006.231-232.265-266.
  • 3Law YM, Quek ST, Tan PH, et al. Adenoid cystic carcinoma of the breast[J]. Singapore Med J, 2009,50(1) :eS-ell.
  • 4Canyilmaz E, Uslu GH, Memit Y, et al. Adenoid cystic carcinoma of the breast A case report and literature review[J]. Oncol Lett,2014,7(5) 1599- 1601.
  • 5Thompson K, Grabowski J, Sahzstein SL, et al, Adenoid cystic breast carcinoma is axillary staging necessary in all cases? Re- suits from the California Cancer Registry. Breast J, 2011,17 (5) .485-489.
  • 6赵兴娟,高润芳,杨璇.实体型腺样囊性乳腺癌临床病例特点及其诊治的分析[J].医学信息,2013.26(7):106.
  • 7Ghabach B, Anderson WF, Curtis RE, et al. Adenoid cystic carcinoma of the breast in the United States( 1977 to 2006):a population based cohort study[J]. Breast Cancer Res, 2010,12 (4) :R54.
  • 8张萍,徐兵河,马飞,李俏,袁苑,王佳玉,张频.晚期三阴性乳腺癌的临床特征及生存分析[J].中华肿瘤杂志,2011,33(5):381-384. 被引量:32
  • 9吴俊东,黄文河,陈明,魏晓龙,马长春,张国君.三阴性乳腺癌与HER-2过表达乳腺癌患者的临床病理特征及预后比较[J].中华内分泌外科杂志,2011,5(3):161-164. 被引量:19
  • 10李淑莲,李丽娟,吴影.36例三阴性乳腺癌的临床与病理分析[J].中国妇幼健康研究,2011,22(3):370-372. 被引量:3

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部